Table 2.
Time to treatment initiation of any treatment modality based on clinical stage at diagnosis comparing Pre-COVID and COVID periods
| Pre-COVID (Median, IQR) | COVID (Median, IQR) | P-value | |
|---|---|---|---|
| TTI for all patients (days) n=23,922 | 51 (30–83) | 49 (29–78) | < 0.0001 |
| TTI for stage I (days) n=9666 | 56 (33–88) | 53 (33–82) | 0.0235 |
| TTI for stage II (days) n=5785 | 58 (35–92) | 57 (34–91) | 0.1538 |
| TTI for stage III (days) n=4987 | 48 (28–77) | 45 (28–76) | 0.1186 |
| TTI for stage IV (days) n=3484 | 36 (20–61) | 34 (21–56) | 0.1027 |
TTI: Time to treatment initiation.